DANIELLE THROWER: Open Payments
NPI 1457321366 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$409 in 13 payments from 11 companies in 2025. Trend: 2023 $297 · 2024 $392 · 2025 $409
Food & beverage: $409
| Company | Payments | Amount |
|---|---|---|
| Kite Pharma, Inc. | 1 | $124 |
| ABBVIE INC. | 2 | $55 |
| Astellas Pharma US Inc | 2 | $42 |
| Genmab U.S., Inc. | 1 | $32 |
| Adaptive Biotechnologies Corporation | 1 | $29 |
| Alexion Pharmaceuticals, Inc. | 1 | $27 |
| Janssen Biotech, Inc. | 1 | $24 |
| Genentech USA, Inc. | 1 | $20 |
| Stemline Therapeutics Inc. | 1 | $20 |
| Rigel Pharmaceuticals, Inc. | 1 | $20 |
Products named: Yescarta, VENCLEXTA, Xospata, Tivdak, clonoSEQ, CARVYKTI, Orserdu, TAVALISSE.
Industry payments across NC — which companies pay providers there.
